In the current study, the patient with MLH1 epimutation was 46 years old, had a history of colorectal cancer (Lynch-associated cancer), had a family history of Lynch-associated cancers, and met the revised Bethesda guidelines. The gene discussed is MLH1; the disease is colorectal cancer.